Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dyne Therapeutics (DYN)
NASDAQ:DYN
Dyne Therapeutics (DYN) Ownership - Who Owns Dyne Therapeutics?
237 Followers
Dyne Therapeutics (DYN) Ownership Overview
46.69% Insiders
14.42% Mutual Funds
11.46% Other Institutional Investors
27.44% Public Companies and Individual Investors
The ownership structure of Dyne Therapeutics (DYN) stock is a mix of institutional, retail and individual investors. Approximately 25.88% of the company’s stock is owned by Institutional Investors, 46.69% is owned by Insiders and 27.44% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 13, 2024 | xxxxxxxxxxxxx | $725344 | |
| Mar 13, 2024 | xxxxxxxxxxxxx | $2815712 | |
| Mar 12, 2024 | Richard William Scalzo Svp, Head Of Finance & Admin | xxxxxxxxxxxxx | $2261465 |
| Mar 12, 2024 | Joshua Brumm Ceo & President,director | xxxxxxxxxxxxx | $10922850 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $214401 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $225416 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $522262 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $8091150 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,954,779 | Institution | 5.06% | 216,771,581 | |
| 4,334,384 | Institution | 4.43% | 189,629,300 | |
| 3,693,047 | Institution | 3.77% | 161,570,806 | |
| 2,962,620 | Institution | 3.03% | 129,614,625 | |
| 1,631,358 | Institution | 1.67% | 71,371,913 | |
| 1,370,746 | Institution | 1.40% | 59,970,138 | |
| 1,088,284 | Institution | 1.11% | 47,612,425 | |
| 963,634 | Institution | 0.98% | 42,158,988 | |
| 926,313 | Institution | 0.95% | 40,526,194 | |
| 902,300 | Institution | 0.92% | 39,475,625 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,962,620 | Institution | 3.03% | 129,614,625 | |
| 1,370,746 | Institution | 1.40% | 59,970,138 | |
| 1,088,284 | Institution | 1.11% | 47,612,425 | |
| 963,634 | Institution | 0.98% | 42,158,988 | |
| 926,313 | Institution | 0.95% | 40,526,194 | |
| 902,300 | Institution | 0.92% | 39,475,625 | |
| 662,251 | Institution | 0.68% | 28,973,481 | |
| 649,740 | Institution | 0.66% | 28,426,125 | |
| 634,808 | Institution | 0.65% | 27,772,850 | |
| 573,928 | Institution | 0.59% | 25,109,350 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,168,755 | Institution | 2.22% | 94,883,031 | |
| 2,626,715 | Institution | 2.68% | 92,696,772 | |
| 1,522,955 | Institution | 1.56% | 67,055,709 | |
| 1,105,562 | Institution | 1.13% | 39,015,283 | |
| 724,754 | Institution | 0.74% | 31,707,988 | |
| 470,744 | Institution | 0.48% | 20,595,050 | |
| 342,917 | Institution | 0.35% | 15,098,636 | |
| 300,422 | Institution | 0.31% | 10,601,892 | |
| 181,105 | Institution | 0.19% | 6,391,195 | |
| 132,422 | Institution | 0.14% | 5,793,463 |
FAQ
Who Owns Dyne Therapeutics (DYN)?
According to the latest TipRanks data, approximately 11.46% of the company's stock is held by institutional investors, 46.69% is held by insiders, and 27.44% is held by retail investors.
What percentage of Dyne Therapeutics (DYN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.46% of Dyne Therapeutics (DYN) stock is held by institutional investors.
What percentage of Dyne Therapeutics (DYN) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.44% of Dyne Therapeutics (DYN) stock is held by retail investors.
Who owns the most shares of Dyne Therapeutics (DYN)?
Peter Kolchinsky owns the most shares of Dyne Therapeutics (DYN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.